参考文献
1.陈新谦，金有豫，汤光.新编药物学.第17版.北京：人民卫生出版社，2011
2.芮耀诚.现代药物学.第1版.北京：人民军医出版社，1999
3.杨世杰.药理学.北京：人民卫生出版社，2005
4.国家食品药品监督管理局药品审评中心、四川美康医药软件研究开发有限公司合编.药物临床信息参考.成都.四川出版集团，四川科学技术出版社.2005
5.陈灏珠、林果为、王吉耀主编.实用内科学.第15版.北京：人民卫生出版社.2017
6.余健民、胡建新主编.呼吸危重症监护及药物治疗学.南昌：江西出版集团、江西科学技术出版社.2007
7.国家药典委员会.中华人民共和国药典临床用药须知：化学药和生物制品卷.2010年版.北京：中国医药科技出版社，2011
8.余健民主编.呼吸内科临床手册.南昌：江西科技出版社.1999
9.傅宏义.新编医院药物大全.第1版.北京：中国医药科技出版社，1999
10.中华医学会编辑出版部：法定计量单位在医学上的应用.第2版.北京：人民军医出版社.1991
11.张文康，潘学田.中国进口药品实用手册1996－1997.第1版.北京：北京科学技术出版社.1996
12.国家药品监督管理局安全监管司，国家药品监督管理局药品评价中心.国家基本药物（西药）.第2版.北京：人民卫生出版社，2002
13.MCDEX合理用药信息支持系统.成都：四川美康医药软件研究开发有限公司.2014／
14.罗明生，高天惠，劳家华.现代临床药物大典.第1版.成都：四川科学技术出版社，2001.360
15.孙琛.临床用药大全.第1版.上海：中国大百科全书出版社上海分社，1995.111
16.余健民、Robert Q.Le主编.血液肿瘤专业实用药物学.南昌：江西出版集团、江西科学技术出版社.2019
17.De Ronchi D，Ruggeri M，Belelli G，et al：Levosulpiride versus pimozide in negative symptoms of schizophrenia.Curr Ther Res 1996b；57：797－809.
18.Piolti R，Appollonio I，Perego M，et al：Proglumide，a cholecystokinin receptor antagonist，reduces neuroleptic action in Huntington′s chorea.Eur Neurol 1995a；35：344－348.
19.Maish WA，McCubbin MM，Letzig LG，et al：Pharmacokinetics of famotidine in patients with cystic fibrosis.J Clin Pharmacol 1998；38：1010－1016.
20.Callaghan JT，Bergstrom RF，Rubin A，et al：A pharmacokinetic profile of nizatidine in man.Scand J Gastroenterol 1987b；22（suppl 136）：9－17.
21.Kinloch JD，Pearson AJG，Woolf IL，et al：The effect of cimetidine on the maintenance of healing of gastric ulceration.Postgrad Med J 1984；60：665－667.
22.Dammann HG，De Looze SM，Bender W，et al：Clinical characteristics of roxatidine acetate.A review.Scand J Gastroenterol 1988；23（suppl 146）：121－134.
23.Johnson DA，Benjamin SB，Whipple J，et al：Efficacy and safety of esomeprazole as maintenance therapy in GERD patients with healed erosive esophagitis（EE）（abstract 330）.Gastroenterology 2000；118（4）：A17.
24.Christensen PB，Albertsen KE，＆Jensen P：Renal failure after omeprazole.Lancet 1993；341：55.
25.Panting KJ，Pinto M，＆Ellison J：Lansoprazole－induced subacute cutaneous lupus erythematosus.Clin Exp Dermatol 2009；34（6）：733－734.
26.Humphries TJ，Nardi RV，Spera AC，et al：Coadministration of rabeprazole sodium（E3810）does not affect the pharmacokinetics of anhydrous theophylline or warfarin（abstract）.Gastroenterology 1996；110（suppl）：138.
27.Correia O，Lomba Viana H，Azevedo R，et al：Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration（letter）.Clin Exp Dermatol 2001；26：455－456.
28.Product Information：DEXILANT oral delayed－release capsules，dexlansoprazole oral delayed－release capsules.Takeda Pharmaceuticals America，Inc.（per manufacturer），Deerfield，IL，2011.
29.Vose CW，Ford GC，Grigson SJW，et al：Pharmacokinetics of propantheline bromide in normal man.Br J Clin Pharmacol 1979；7：89－93.
30.Cotton BR＆Smith G：Comparison of the effects of atropine and glycopyrrolate on lower oesophageal sphincter pressure.Br J Anaesth 1981；53：875－879.
31.Brunner H，Kittrich H，Kratochvil P，et al：Treatment of duodenal ulcer with pirenzepine and cimetidine.Gut 1984；25：206－210.
32.Windrim R，Bennett K，Mundle W，et al：Oral administration of misoprostol for labor induction：a randomized controlled trial.Obstet Gynecol 1997；89：392－397.
33.Reed PI，Lewis SI，Vincent－Brown A，et al：The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer.Scand J Gastroenterol 1980；15：51－55.
34.Naito Y，Yoshikawa T，Iinuma S，et al：Rebamipide protects against indomethacin－induced gastric mucosal injury in healthy volunteers in a doubleblind，placebo－controlled study.Dig Dis Sci 1998；43（suppl 9）：S83－S89.
35.Melga P，Mansi C，Ciuchi E，et al：Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis.Diabetes Care 1997；20：55－58.
36.Ohki R，Takahashi M，Mizuno O，et al：Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia.PACE 2001；24：119－121.
37.Product Information：LOTRONEX（R）oral tablets，alosetron hydrochloride oral tablets.Prometheus Laboratories Inc，San Diego，CA，2010.
38.Kasinath NS，Malak O，＆Tetzlaff J：Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting：a case report.Can J Anaesth 2003a；50（3）：229－231.
39.Product Information：APOKYN（R）subcutaneous injection，apomorphine HCl subcutaneous injection.Ipsen Developments Limited，Slough，Berkshire，SL1 3XE，United Kingdom，2009.
40.Freedman SB，Powell EC，Nava－Ocampo AA，et al：Ondansetron dosing in pediatric gastroenteritis：a prospective cohort，dose－response study.Paediatr Drugs 2010；12（6）：405－410.
41.Lippert C，Keung A，Arumugham T，et al：The effect of food on the bioavailability of dolasetron mesylate tablets.Biopharm Drug Dispos 1998；19：17－19.
42.Product Information：KYTRIL（R）IV injection，granisetron HCl IV injection.Genentech USA，Inc，South San Francisco，CA，2011.
43.Alon E，Buchser E，Herrera E，et al：Tropisetron for treating established postoperative nausea and vomiting：a randomized，double－blind，placebocontrolled study.Anesth Analg 1998；86：617－623.
44.Shah A，Lanman R，Bhargava V，et al：Pharmacokinetics of dolasetron following single－and multiple－dose intravenous administration to normal male subjects.Biopharmaceut Drug Disp 1995；16：177－189.
45.Product Information：KYTRIL（R）IV injection，granisetron HCl IV injection.Genentech USA，Inc，South San Francisco，CA，2011.
46.Alon E，Buchser E，Herrera E，et al：Tropisetron for treating established postoperative nausea and vomiting：a randomized，double－blind，placebocontrolled study.Anesth Analg 1998；86：617－623.
47.Shah A，Lanman R，Bhargava V，et al：Pharmacokinetics of dolasetron following single－and multiple－dose intravenous administration to normal male subjects.Biopharmaceut Drug Disp 1995；16：177－189.
48.Zambelli A，Sagrada P，＆Pavesi L：Seizure associated with palonosetron.Support Care Cancer 2009；17（3）：217－217.
49.Stacher G，Weber U，Stacher－Janotta G，et al：Effects of the 5－HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man：a double－blind crossover trial.Br J Clin Pharmacol 2000；49：429－436.
50.Giaccone G，Bertetto O，Secat MA，et al：High doses of methylprednisolone with or without alizapride in the prevention of cisplatin－induced emesis：a randomized，double－blind，crossover study.Oncology 1988；45：74－78.
51.Product Information：LOTRONEX（R）oral tablets，alosetron hydrochloride oral tablets.Prometheus Laboratories Inc，San Diego，CA，2010.
52.Product Information：Dicetel（R），pinaverium bromide tablets.Solvay Kingswood，Inc.，Scarborough，Ontario，Canada，1993b.
53.Tudor G：A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome.Br J Clin Pract Suppl 1986；40（7）：276－278.
54.Sharma JB，Pundir P，Kumar A，et al：Drotaverine hydrochloride vs.valethamate bromide in acceleration of labor.Int J Gynecol Obstet 2001；74：255－260.
55.FDALabel（2011－08－01）－BENTYL（Dicyclomine Hydrochloride Tablets，Capsules，Oral Syrup，Injection）（Axcan Pharma US，Inc.）
56.FDALabel（2014－06－26）－GATTEX（Teduglutide for Injection）（NPS Pharmaceuticals）
57.Product Information：glucagon injection，glucagon injection.Eli Lilly and Company，Indianapolis，IN，2005.
58.Swan SK，Zhou H，Horowitz A，et al：Tegaserod pharmacokinetics are similar in patients with severe renal insufficiency and in healthy subjects.J Clin Pharmacol 2003a；43：359－364.
59.Depierre A，Lebeau B，d′Allens H，et al：A comparison of ondansetron with alizapride plus methylprednisolone in the control of cisplatin－induced emesis.Oncology 1992；49：305－311.
60.FDALabel（2015－08－28）－EMEND（Aprepitant Capsules）（Merck Sharp＆Dohme Corp.）
61.Freedman SB，Powell EC，Nava－Ocampo AA，et al：Ondansetron dosing in pediatric gastroenteritis：a prospective cohort，dose－response study.Paediatr Drugs 2010；12（6）：405－410.
62.Product Information：Vontrol（R），diphenidol.Smith Kline＆French Labs，Philadelphia，PA，1996.
63.Henzi I，Walder B，＆Tramer MR：Metoclopramide in the prevention of postoperative nausea and vomiting：a quantitative systemic review of randomized，placebo－controlled studies.Br J Anaesth 1999；83（5）：761－771.
64.Mikkelson EJ，Detlor J，Cohen DJ，et al：School avoidance and social phobia triggered by haloperidol in patients with Tourette′s disorder.Am J Psychiatry 1981；138：1572－1576.
65.Product Information：Inapsine（R），droperidol.Akorn Manufacturing Inc.，Decatur，IL，2002v.
66.Product Information：EMEND（R）IV injection，fosaprepitant dimeglumine IV injection.Merck Sharp＆Dohme Corp，Whitehouse Station，NJ，2010.
67.Product Information：KYTRIL（R）IV injection，granisetron HCl IV injection.Genentech USA，Inc，South San Francisco，CA，2011.
68.Olver IN，Craft PS，Clingan PR，et al：An open multicentre study of tropisetron for cisplatin－induced nausea and vomiting.Med J Aust 1996；164：337－340.
69.Henzi I，Walder B，＆Tramer MR：Metoclopramide in the prevention of postoperative nausea and vomiting：a quantitative systemic review of randomized，placebo－controlled studies.Br J Anaesth 1999；83（5）：761－771.
70.Kotzailias N，Finsterer J，Aull S，et al：Influence of tiapride on platelet counts in healthy volunteers and patients with movement disorders.Prog Neuropsychopharmacol Biol Psychiatry 2003；27（4）：595－599.
71.Product Information：Torecan（R），thiethylperazine.Boehringer Ingelheim，Ridgefield，CT，1995.
72.Luisto M：Polyneuropathy caused by chlorprothixene.Acta Psych Scand 1992；85：246－248.
73.FDALabel（2015－09－01）－VARUBI（Rolapitant HCl Tablets）（TESARO，Inc.）
74.Sands CD，Robinson JD，Salem RB，et al：Effect of thioridazine on phenytoin serum concentration：a retrospective study.Drug Intell Clin Pharm 1987；21：267－272.
75.FDALabel（2014－10－10）－AKYNZEO（Netupitant and PalonosetronHydrochloride Capsules）（Helsinn Healthcare）
76.Borda I＆Jick H：Hepatitis following the administration of trimethobenzamide hydrochloride.Arch Intern Med 1967；120：371.
77.Mikkelson EJ，Detlor J，Cohen DJ，et al：School avoidance and social phobia triggered by haloperidol in patients with Tourette′s disorder.Am J Psychiatry 1981；138：1572－1576.
78.Vestre ND＆Schiele BC：Differential drug effects of two phenothiazines：A controlled comparison of thioridazine and trifluoperazine in chronic schizoprenics.Dis Nerv Syst 1970；31：821.
79.Ohmoto K，Yamamoto S，＆Hirokawa M：Symptomatic primary biliary cirrhosis triggered by administration of sulpiride（letter）.Am J Gastroenterol 1999；94（12）：3660－3661.
80.Dogliotti L，Antonacci RA，Paze E，et al：Three years experience with tropisetron in the control of nausea and vomiting in cisplatin－treated patients.Drugs 1992；43（suppl 3）：6－10.
81.Wang RIH，Larson C，＆Treul SJ：Study of penfluridol and chlorpromazine in the treatment of chronic schizophrenia.J Clin Pharmacol 1982c；22：236－242
82.Molino A，Guglielmo L，Azzolini ME，et al：The antiemetic activity of high－dose metoclopramide and high－dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy：a prospective，randomized，double－blind study.Oncology 1991b；48：111－115.
83.Kasinath NS，Malak O，＆Tetzlaff J：Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting：a case report.Can J Anaesth 2003a；50（3）：229－231.
84.Product Information：Vontrol（R），diphenidol.Smith Kline＆French Labs，Philadelphia，PA，1996.
85.Product Information：KYTRIL（R）IV injection，granisetron HCl IV injection.Genentech USA，Inc，South San Francisco，CA，2011.
86.Henzi I，Walder B，＆Tramer MR：Metoclopramide in the prevention of postoperative nausea and vomiting：a quantitative systemic review of randomized，placebo－controlled studies.Br J Anaesth 1999；83（5）：761－771.
87.Lepola U，Kokko S，Nuutila J，et al：Tiapride and chlordiazepoxide in acute alcohol withdrawal.A controlled clinical trial.Int J Clin Pharm Res 1984a；6：321－326.
88.Luisto M：Polyneuropathy caused by chlorprothixene.Acta Psych Scand 1992；85：246－248.
89.Zambelli A，Sagrada P，＆Pavesi L：Seizure associated with palonosetron.Support Care Cancer 2009；17（3）：217－217.
90.Simons FE，Watson WTA，Chen XY，et al：The pharmacokinetics and pharmacodynamics of hydroxyzine in patients with primary biliary cirrhosis.J Clin Pharmacol 1989；29：809－815.
91.Borda I＆Jick H：Hepatitis following the administration of trimethobenzamide hydrochloride.Arch Intern Med 1967；120：371.6.AMA Council on Drugs：AMA Drug Evaluations，4th.American Medical Association，Chicago，1980.
92.Product Information：trifluoperazine HCl oral tablets，trifluoperazine HCl oral tablets.Sandoz Inc.，Princeton，NJ，2010.
93.Allen D，Jorgensen C，＆Sims C：Effect of tropisetron on vomiting during patient－controlled analgesia in children.Br J Anaesth 1999；83（4）：608－610.
94.Melga P，Mansi C，Ciuchi E，et al：Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis.Diabetes Care 1997；20：55－58.
95.Galvez－Jimenez N＆Lang AE：Perioperative problems in Parkinson′s disease and their management：apomorphine with rectal domperidone.Can J Neurol Sci 1996；23：198－203.
96.Product Information：Dulcolax（R），bisacodyl.Boehringer Ingelheim Pharmaceuticals，Ridgefield，CT，1994b.
97.Product Information：Fleet Flavored Castor Oil（R），castor oil.Fleet，Lynchbury，VA，1993.
98.Sidhu PS，Wilkinson ML，Sladen GE，et al：Fatal phenolphthalein poisoning with fulminant hepatic failure and disseminated intravascular coagulation.Human Toxicol 1989；8：381－384.
99.FDALabel（2012－08－30）－LINZESS（Linaclotide Capsules）（Forest Pharmaceuticals，Inc.）
100.Product Information：Colace（R），docusate sodium.Apothecon，Princeton，NJ，1993.
101.Product Information：Amitiza（R）oral capsules，lubiprostone oral capsules.Sucampo Pharma Americas，Inc and Takeda Pharmaceuticals America，Inc，Bethesda，MD，2011.
102.Dupont C，Leluyer B，Maamri N，et al：Double－blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children.J Pediatr Gastroenterol Nutr 2005；41（5）：625－633.
103.Pitlick WH，Pirikitakuhir P，Painter MJ，et al：Effects of glycerol and hyperosmolality on intracranial pressure.Clin Pharmacol Ther 1982；31：466－471.
104.Product Information：sorbitol 70% solution oral solution，rectal solution，sorbitol 70% solution oral solution，rectal solution.Qualitest Pharmaceuticals，Huntsville，AL，2008.
105.Pimparker BD，Pavstian FF，Roth JLA，et al：Effect of polycarbophil on diarrhea and constipation.Gastroenterology 1961；40：397－404.
106.FDALabel（2012－07－16）－PREPOPIK（Sodium Picosulfate，Magnesium Oxide and Anhydrous Citric Acid Powder for Oral Solution）（Ferring Pharmaceuticals Inc.）
107.Product Information：LOTRONEX（R）oral tablets，alosetron hydrochloride oral tablets.Prometheus Laboratories Inc，San Diego，CA，2010.
108.FDALabel（2015－05－27）－VIBERZI（Eluxadoline Tablets）（Patheon Pharmaceuticals，Inc.）
109.McFarland LV，Surawicz CB，Greenberg RN，et al：Prevention of beta－lactam－associated diarrhea by Saccharomyces boulardii compared with placebo.Am J Gastroenterol 1995a；90：439－448
110.Product Information：LOMOTIL（R）CV oral tablets，oral liquid，diphenoxylate hcl，atropine sulfate oral tablets，oral liquid.GD Searle LLC，New York，NY，2005.
111.FDALabel（2012－12－31）－FULYZAQ（Crofelemere Dlayed－Releasea
Tblets）（Salix Pharmaceuticals，Inc.）
112.Tytgat GN＆Huibregtse K：Loperamide and ileostomy output－placebo－controlled，doubleblind，crossover study.Br Med J 1975；2：667.
113.Braddette M，Moeonnikes H，Carter F et al：Cilansetron in irritable bowel syndrome with diarrhea predominance（IBS－D）：efficacy and safety in a 6 month global study.Presented at Digestive Disease Week；New Orleans，LA，2004；May 15－20.
114.Cezard JP，Duhamel JF，Meyer M，et al：Efficacy and tolerability of racecadotril in acute diarrhea in children.Gastroenterology 2001；120（4）：799－805.
115.Buts JP，Petit BF，＆de Meyer R：Loperamide in treatment of persistent diarrhoea in children（letter）.Br Med J 1975a；3：766－767
116.Anon：American Academy of Clinical Toxicology；European Association of Poison Centres and Clinical Toxicologists：Position statement：singledose activated charcoal.J Toxicol Clin Toxicol 1997a；35：721－741.
117.Product Information：R－GENE（R）10 IV injection，10% arginine hcl IV injection.Pharmacia＆Upjohn Company，Kalamazoo，MI，2003.
118.Spigset O：Reduced effect of warfarin caused by ubidecarenone.Lancet 1994；344：1372－1373.
119.Testa B，Mesolella M，Testa D，et al：Glutathione in the upper respiratory tract.Ann Otol Rhinol Laryngol 1995a；104：117－119.
120.Bohm S，Oriana S，Spatti G，et al：Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma.Oncology 1999；57：115－120.
121.Product Information：R－GENE（R）10 IV injection，10% arginine hcl IV injection.Pharmacia＆Upjohn Company，Kalamazoo，MI，2003.
122.FDALabel（2010－03－18）－CARBAGLU（Carglumic Acid Tablets）（Orphan Europe SARL，Paris，France）
123.Hayase Y，Fukatsu H，＆Segawa A：The dissolution of cystine stones by irrigated tiopronin solution.J Urol 1980；124：775－778.
124.Vaidyanathan S，Soni BM，＆Krishnan KR：Special precautions to be observed while using alprostadil in patients with spinal cord injury.Spinal Cord 1997；35：402－403.
125.Dupont C，Leluyer B，Maamri N，et al：Double－blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children.J Pediatr Gastroenterol Nutr 2005；41（5）：625－633.
126.Bonfiglio MF，Traeger SM，Hulisz DT，et al：Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities.Ann Pharmacother 1992；26：22－25.
127.Piolti R，Appollonio I，Perego M，et al：Proglumide，a cholecystokinin receptor antagonist，reduces neuroleptic action in Huntington′s chorea.Eur Neurol 1995a；35：344－348.
128.Iser JH＆Sali A：Chenodeoxycholic acid：a review of its pharmacological properties and therapeutic use.Drugs 1981a；21：90－119.
129.Peters GA＆Witten DM：Anaphylactic reaction after sodium dehyrocholate（decholin）use.Minn Med 1971；54：787－788.
130.FDALabel（2008－09）－KINEVAC（Sincalide For Injection）（Bracco Diagnostics Inc.）
131.Shiffman ML，Kaplan GD，Brinkman－Kaplan V，et al：Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very－low－calorie diet program.Ann Intern Med 1995；122：899－905.
132.Product Information：ENTEREG（R）oral capsules，alvimopan oral capsules.Adolor Corporation，Exton，PA，2009.
133.Product Information：MYTELASE（R）oral tablets，ambenonium chloride oral tablets.Sanofi－Aventis U.S.LLC（per FDA），Bridgewater，NJ，2011.
134.Neef B，Hoering E，＆v Gaisberg U：Erfolgreiche Behandlung einer lebensbedrohlichen Ileostoma－Diarrhoe mit dem Somatostatin－Analogon Octreotid.Dtsch Med Wochenschr 1994；119：869－874.
135.Ryde EM＆Ahnfelt NO：The pharmacokinetics of olsalazine sodium in healthy volunteers after a single IV dose and after oral doses with and without food.Eur J Clin Pharmacol 1988a；34：481－488.
136.Ryde M，Sandberg－Gertzen H，Jarnerot G，et al：Is 5－aminosalicyclic acid delivered directly to the colon by olsalazine？.Scand J Gastroenterol 1988；23（suppl 148）：104－106.
137.FDALabel（2012－02－03）－GIAZO（Balsalazide Disodium Tablets）（Salix Pharmaceuticals，Inc.）
138.Ripamonti C，DeConno F，Boffi R，et al：Can somatostatin be administered in association with morphine in advanced cancer patients with pain（letter）？.Ann Oncol 1998；9：921－924.
139.Cales P，Masliah C，Bernard B，et al：Early administration of vapreotide for variceal bleeding in patients with cirrhosis.French Club for the Study of Portal Hypertension..N Engl J Med 2001；344：23－28.
140.Pederzoli P，Cavallini G，Falconi M，et al：Gabexate mesilate vs aprontinin in human acute pancreatitis（GA.ME.P.A.）：a prospective，randomized double－blind multicenter study.Intern J Pancreatol 1993b；14：117－124.
141.Pimparker BD，Pavstian FF，Roth JLA，et al：Effect of polycarbophil on diarrhea and constipation.Gastroenterology 1961；40：397－404.
142.FDALabel（2014－03－04）－Azulfidine（Sulfasalazine Tablets）（Pharmacia＆Upjohn Co）
143.Lizasoain J，Rubio FA，Erdozain JC，et al：Folliculitis and mesalamine（letter）.Am J Gastroenterol 1996；91：819－820.
144.FDALabel（2014－09－16）－MOVANTIK（Naloxegol Tablets）（AstraZeneca Pharmaceuticals LP）
145.Iwama H，Nakane M，Ohmori S，et al：Nafamostat mesilate，a kallikrein inhibitor，prevents pain on injection with propofol.Br J Anaesth 1998；81：963－964.
146.Product Information：Sucraid（R）sucrosidase oral solution.Nutramax Products，Inc.，Gloucester，MA，2003.
147.Ripamonti C，DeConno F，Boffi R，et al：Can somatostatin be administered in association with morphine in advanced cancer patients with pain（letter）？.Ann Oncol 1998；9：921－924.
148.Stephan F＆Paillard F：Terlipressin－exacerbated hypokalaemia.Lancet 1998；351：1249－1250.
149.Product Information：SonoRx（R），simethicone coated cellulose suspension.Bracco Diagnostics，Inc，Princeton，NJ，1998b.
150.FDALabel（2014－09－29）－RELISTOR（Methylnaltrexone Bromide Injection）（Salix Pharmaceuticals，Inc.）
151.Product Information：nystatin oral suspension，nystatin oral suspension.Taro Pharmaceuticals，Inc，Hawthorne，NY，2006.
152.Dunn TE，Ludwig EA，Slaughter RL，et al：Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.Clin Pharmacol Ther 1991；49：536－549.
153.Mercer PM，Ebbs SR，Fraser SC，et al：Trial of aminoglutethimide vs hydrocortisone as second－line hormone treatment of advanced breast cancer.Eur J Surg Oncol 1993；19（3）：254－258.
154.Hendy P＆Turner AS：Pulmonary infiltrative eosinophilia and beclomethasone dipropionate.N Z Med J 1981；94：394.
155.Lundin J，Osterborg A，Bjorkholm M，et al：Phase II study of cyclophosphamide，interferonalpha and betamethasone（CIB）as induction therapy for patients 60－75 years of age with multiple myeloma stages II and III.Hematol J 2003；4（4）：248－252.
156.Oteri A，Bussolini A，Sacchi M，et al：A case of atrial fibrillation induced by inhaled fluticasone propionate.Pediatrics 2010；126（5）：e1237－e1241
157.Product Information：CLOBEX（R）topical lotion，clobetasol propionate topical lotion.DPT Laboratories，Ltd.，San Antonio，TX，2005
158.Product Information：ENTOCORT（R）EC oral capsules，budesonide oral capsules.Prometheus Laboratories Inc.（per FDA），San Diego，CA，2011.
159.Product Information：hydrocortisone topical cream，lotion，ointment，hydrocortisone topical cream，lotion，ointment.Taro Pharmaceuticals USA，Inc，Hawthorne，NY，2003.
160.Parodi MB，Iacono P，De Benedetto U，et al：Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion.J Ocul Pharmacol Ther 2012；28（6）：566－568.
161.FDALabel（2001－07－13）－FML（Fluorometholone Ophthalmic Ointment）（Allergan，Inc.）
162.Dellinger RP，Levy MM，Carlet JM，et al：Surviving Sepsis Campaign：international guidelines for management of severe sepsis and septic shock：2008.Crit Care Med 2008；36（1）：296－327.
163.FDALabel（2012－03－16）－VANOS（Fluocinonide Cream）（Contract Pharmaceuticals Ltd.）
164.Product Information：Cortone（R），cortisone acetate.Merck＆Co.，Inc.，West Point，PA，1997a.
165.Mofenson LM，Oleske J，Serchuck L，et al：Treating opportunistic infections among HIV－exposed and infected children：recommendations from CDC，the National Institutes of Health，and the Infectious Diseases Society of America.MMWR Recomm Rep 2004；53（RR－14）：1－92.
166.Fuse H，Nozaki T，Fujiuchi Y，et al：Treatment with prednisolone of hormone－refractory prostate cancer.Arch Androl 2006；52（1）：35－38.
30.Lexi－Drugs［PrednisoLONE（Systemic）］
167.Product Information：KENALOG（R）－10 intra－articular intralesional suspension for injection，triamcinolone acetonide intra－articular intralesional suspension for injection.Bristol－Myers Squibb Company（per FDA），Princeton，NJ，2011a.
168.Kusama M，Sakauchi N，＆Numaoka S：Studies of plasma levels and urinary excretion after intramuscular injection of triamcinolone acetonide.Metabolism 1971a；20：590－596.
169.FDALabel（2014－07－22）－DESONATE（Desonide Gel）（Bayer HealthCare Pharmaceuticals Inc.）
170.FDALabel（2012－11－16）－AEROSPAN（Flunisolide Inhalation Aerosol）（Acton Pharmaceuticals，Inc.）
171.Product Information：Florinef（R），fludrocortisone acetate tablets，USP.Bristol－Myers Squibb Company，Princeton，NJ，2002
172.FDALabel（2013－07－23）－Cordran（Flurandrenolide SP Cream and Ointment）（Aqua Pharmaceuticals，LLC）
173.Oteri A，Bussolini A，Sacchi M，et al：A case of atrial fibrillation induced by inhaled fluticasone propionate.Pediatrics 2010；126（5）：e1237－e1241.
174.FDALabel（2012－01－20）－ZETONNA（ciclesonide Nasal Aerosol 7 For Intranasal）（Sunovion Pharmaceuticals Inc）
175.Dunn TE，Ludwig EA，Slaughter RL，et al：Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.Clin Pharmacol Ther 1991；49：536－549.
176.Oteri A，Bussolini A，Sacchi M，et al：A case of atrial fibrillation induced by inhaled fluticasone propionate.Pediatrics 2010；126（5）：e1237－e1241.
177.FDALabel（2013－04－19）－ELOCON（Mometasone Furoate Cream）（MERCK＆CO.，INC.）
178.FDALabel（2012－02－22）－VEXOL（Rimexolone Ophthalmic Suspension）（ALCON LABORATORIES，INC.）
179.FDALabel（2012－04－02）－ULTRAVATE（Halobetasol Propionate
Cream，Ointment）（RANBAXY）
180.Montoro J，Valero A，Serra－Baldrich E，et al：Anaphylaxis to paramethasone with tolerance to other corticosteroids.Allergy 2000；55（2）：197－198
181.Kusama M，Sakauchi N，＆Numaoka S：Studies of plasma levels and urinary excretion after intramuscular injection of triamcinolone acetonide.Metabolism 1971a；20：590－596.
182.FDALabel（2012－09－28）－LOTEMAX（Loteprednol Etabonate Ophthalmic Gel）（Bausch＆Lomb Incorporated）
183.FDALabel（2014－06－16）－SAIZEN［Somatropin（rDNA origin）for Injection］（EMD Serono Inc.）
184.Neef B，Hoering E，＆v Gaisberg U：Erfolgreiche Behandlung einer lebensbedrohlichen Ileostoma－Diarrhoe mit dem Somatostatin－Analogon Octreotid.Dtsch Med Wochenschr 1994；119：869－874.
185.FDALabel（2014－12－22）－SOMATULINE DEPOT（Lanreotide Acetate Injection）（Ipsen Pharma Biotech）
186.Torres AJ，Landa JIM，Moreno－Azcoita M，et al：Somatostatin in the management of gastrointestinal fistula：a multicenter trial.Arch Surg 1992；127：97－100.
187.Cales P，Masliah C，Bernard B，et al：Early administration of vapreotide for variceal bleeding in patients with cirrhosis.French Club for the Study of Portal Hypertension..N Engl J Med 2001；344：23－28.
188.FDALabel（2014－12－22）－SOMATULINE DEPOT（Lanreotide Acetate Injection）（Ipsen Pharma Biotech）
189.Choi TK，Mok F，Zhan WH，et al：Somatostatin in the treatment of acute pancreatitis：a prospective randomised controlled trial.Gut 1989；30：223－227.
190.Cales P，Masliah C，Bernard B，et al：Early administration of vapreotide for variceal bleeding in patients with cirrhosis.French Club for the Study of Portal Hypertension..N Engl J Med 2001；344：23－28.
191.FDALabel（2012－12－14）－SIGNIFOR（Pasireotide Diaspartate Injection）（Novartis Pharma Stein AG）
192.FDALabel（2013－12－10）－SOMAVERT（Pegvisomant for Injection）（Pharmacia and Upjohn Co）
193.Product Information：H.P.ACTHAR GEL（R）gel for intramuscular／subcutaneous injection，repository corticotropin gel for intramuscular／subcutaneous injection.Questcor Pharmaceuticals，Inc，Union City，CA，2010.
194.FDALabel（2011－03－24）－CYCLOSET（Bromocriptine Mesylate Tablets）（Santarus，Inc.）
195.FDALabel（2010－11－04）－METOPIRONE（Metyrapone Capsules）（R.P.Scherer GmbH）
196.FDALabel（2010－11）－EGRIFTA（Tesamorelin Injection）（EMD Serono，Inc.）
197.Macleod AF，Wheeler MJ，Gordon P，et al：Effect of long－term inhibition of gonadotropin secretion by the gonadotrophin－releasing hormone agonist，buserelin，on sex steroid secretion and ovarian morphology in polycystic ovary syndrome.J Endocrinol 1990；125：317－325.
198.Product Information：Luveris（R），lutropin alfa for injection.Serono，Inc.，Rockland，MD，2004.
199.Product Information：GONAL－F（R）injection，follitropin alfa injection.Serono，Inc，Rockland，MA，2005.
200.FDALabel（2012－01－23）－LUPRON（leuprolide acetate for susperion）（Abbott Laboratories）
201.Johansen JS，Riis BJ，Hassager C，et al：The effect of a gonadotropin－releasing hormone agonist analog（nafarelin）on bone metabolism.J Clin Endocrinol Metab 1988；67：701－706.
202.Product Information：Bravelle（TM），urofollitropin for injection（FSH）.Ferring Pharmaceuticals，Inc.，Albuquerque，NM，2002.
203.Muller FO，Terblanche J，Schall R，et al：Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency.Br J Clin Pharmacol 1997；44：335－341.
204.FDALabel（2013－04－02）－SSUPPRELIN LA（Histrelin Acetate Subcutaneous Implant）（Endo Pharmaceuticals Solutions Inc.）
205.Product Information：FACTREL（TM）injection，gonadorelin hcl injection.Baxter Healthcare Corporation，Deerfield，IL，2003.
206.Product Information：chorionic gonadotropin intramuscular injection，chorionic gonadotropin intramuscular injection.APP Pharmaceuticals，LLC，Schaumburg，IL，2008.
207.Product Information：GONAL－F（R）injection，follitropin alfa injection.Serono，Inc，Rockland，MA，2004.
208.Product Information：chorionic gonadotropin intramuscular injection，chorionic gonadotropin intramuscular injection.APP Pharmaceuticals，LLC，Schaumburg，IL，2008.
209.Product Information：Luveris（R），lutropin alfa for injection.Serono，Inc.，Rockland，MD，2004.
210.Product Information：GONAL－F（R）injection，follitropin alfa injection.Serono，Inc，Rockland，MA，2005.
211.Product Information：Luveris（R），lutropin alfa for injection.Serono，Inc.，Rockland，MD，2004.
212.Product Information：Profasi（R），chorionic gonadotropin.Serono Laboratories，Inc，Norwell，MA，1999.
213.Product Information：VANTAS（R）subcutaneous implant，histrelin acetate subcutaneous implant.Endo Pharmaceuticals Solutions Inc.，Chadds Ford，PA，2011
214.Szumita PM，Enfanto CM，Greenwood B，et al：Vasopressin for vasopressor－dependent septic shock.Am J Health－Syst Pharm 2005；62：1931－1936.
215.Product Information：HUMALOG（R）subcutaneous injection，insulin lispro［rDNA origin］subcutaneous injection.Lilly USA，LLC（per manufacturer），Indianapolis，IN，2011.
216.Jacobsen LV，Popescu G，＆Plum A：Pharmacokinetics of insulin detemir in subjects with renal or hepatic impairment（abstract 413－P）.Diabetes 2002；51（2）：A102.
217.FDALabel（2015－02－25）－APIDRA［Insulin Glulisine（rDNA Origin）Injection］（sanofiaventis U.S.LLC）
218.Skoutakis V，Black WD，Acchiardo SR，et al：Peritoneal dialysis in the treatment of acetohexamide－induced hypoglycemia.Am J Hosp Pharm 1977；34：68.
219.FDALabel（2013－10－15）－DiaBeta（Glyburide Tablets）（sanofi－aventis U.S.LLC）
220.Kradjan WA，Kobayashi KA，Bauer LA，et al：Glipizide pharmacokinetics：effects of age，diabetes，and multiple dosing.J Clin Pharmacol 1989；29：1121－1127
221.Kradjan WA，Kobayashi KA，Bauer LA，et al：Glipizide pharmacokinetics：effects of age，diabetes，and multiple dosing.J Clin Pharmacol 1989；29：1121－1127
222.Product Information：Glurenor（R），gliquidone.Laboratori Guidotti S.p.A，Pisa，Italy，1999.
223.Product Information：AMARYL（R）oral tablets，glimepiride oral tablets.Sanofi－Aventis U.S.LLC，Bridgewater，NJ，2008.
224.Product Information：Orinase（R），tolbutamide.Smithkline Beecham Pharmaceuticals，Philadelphia，PA，1994.
225.Product Information：DIABINESE（R）oral tablets，chlorpropamide oral tablets.Pfizer Labs，New York，NY，2009.
226.FDALabel（2015－03－16）－AVANDARYL（Rosiglitazone Maleate and Glimepiride Tablets）（GlaxoSmithKline）
227.Product Information：Tolazamide oral tablets，Tolazamide oral tablets.Mylan Pharmaceuticals Inc，Morgantown，WV，2009.
228.FDALabel（2015－05－07）－TANZEUM（Albiglutide for Injection）（GlaxoSmithKline）
229.FDALabel（2014－09－18）－TRULICITY（Dulaglutide Injection）（Eli Lilly and Company）
230.Product Information：STARLIX（R）oral tablets，nateglinide oral tablets.Novartis Pharmaceuticals Corporation，East Hanover，NJ，2008.
231.Product Information：PRANDIN（R）oral tablets，repaglinide oral tablets.Novo Nordisk，Inc，Princeton，NJ，2006.
232.Kwong SC＆Brubacher J：Phenformin and lactic acidosis：a case report and review.J Emerg Med 1998；16（6）：881－886.
233.Product Information：METAGLIP（TM）oral tablets，glipizide and metformin HCl oral tablets.Bristol－Myers Squibb Company，Princeton，NJ，2009.
234.FDALabel（2013－05－24）－KOMBIGLYZE XR（Ssaxagliptin and Metformin Hydrochloride Extended－Release Tablets）（Bristol－Myers Squibb Company）
235.FDALabel（2015－04－27）－JANUMET XR（Sitagliptin and Metformin HCl Extended－Release Tablets）（Merck Sharp＆Dohme Corp.）
236.Kono T，Hayami M，Kobayashi H，et al：Acarbose－induced generalised erythema multiforme.Lancet 1999；354（9176）：396－397.
237.Matsumoto K，Yano M，Miyake S，et al：Effects of voglibose on glycemic excursions，insulin secretion，and insulin sensitivity in non－insulintreated NIDDM patients.Diabetes Care 1998；21：256－260.
238.Product Information：GLYSET（R）oral tablets，miglitol oral tablets.Pharmacia＆Upjohn Company，New York，NY，2009.
239.Product Information：ACTOS（R）oral tablets，pioglitazone hydrochloride oral tablets.Takeda Pharmaceuticals America，Inc.，Deerfield，IL，2008.
240.FDALabel（2008）－AVANDIA（Rosiglitazone Maleate Tablet）（GlaxoSmithKline）
241.Product Information：ACTOS（R）oral tablets，pioglitazone hydrochloride oral tablets.Takeda Pharmaceuticals America，Inc，Deerfield，IL，2011.
242.FDALabel（2015－03－16）－AVANDARYL（Rosiglitazone Maleate and Glimepiride Tablets）（GlaxoSmithKline）
243.FDALabel（2013－01－25）－NESINA（Alogliptin Tablets）（Takeda Pharmaceuticals America，Inc.）
244.Nielsen LL＆Baron AD：Pharmacology of exenatide（synthetic exendin－4）for the treatment of type 2 diabetes（review）.Curr Opin Invest Drugs 2003；4（＄）：401－405.
245.Kolterman OG，Schwartz S，Corder C，et al：Effect of 14 days′subcutaneous administration of the human amylin analogue，pramlintide（AC137），on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.Diabetologia 1996；39：492－499.
246.FDALabel（2014－08－08）－FARXIGA（Dapagliflozin Tablets）（Bristol－Myers Squibb Company）
247.FDALabel（2015－09－10）－INVOKANA（Canagliflozin Tablets）（Janssen Pharmaceuticals，Inc.）
248.FDALabel（2015－08－28）－TRADJENTA（Linagliptin Tablets）（Boehringer Ingelheim Pharmaceuticals，Inc.）
249.FDALabel（2015－03－09）－Victoza［Liraglutide（rDNA Origin）Injection］（Novo Nordisk A／S）
250.FDALabel（2015－08－28）－JANUVIA（Sitagliptin Phosphate Tablets）（Merck Sharp＆Dohme Corp.）
251.Gleiter CH，Schug BS，Hermann R，et al：Influence of food intake on the bioavailability of thioctic acid enantiomers.Eur J Clin Pharmacol 1996；50：513－514.
252.FDALabel（2014－06－27）－SYMLIN（Pramlintide Acetate Injection）（AstraZeneca Pharmaceuticals LP）
253.Lepola UM，Wade AG，Leinonen EV，et al：A controlled，prospective，1－year trial of citalopram in the treatment of panic disorder.J Clin Psychiatry 1998；59（10）：528－534.
254.Scirica BM，Braunwald E，Raz I，et al：Heart Failure，Saxagliptin and Diabetes Mellitus：Observations from the SAVOR－TIMI 53 Randomized Trial.Circulation 2014；Epub：Epub.
255.Ristic S，Byiers S，Foley J，et al：Improved glycaemic control with dipeptidyl peptidase－4 inhibition in patients with type 2 diabetes：vildagliptin（LAF237）dose response.Diabetes Obes Metab 2005；7（6）：692－698.
256.FDALabel（2015－08－28）－JANUVIA（Sitagliptin Phosphate Tablets）（Merck Sharp＆Dohme Corp.）
257.Lepola UM，Wade AG，Leinonen EV，et al：A controlled，prospective，1－year trial of citalopram in the treatment of panic disorder.J Clin Psychiatry 1998；59（10）：528－534.
258.Jinno M，Yoshimura Y，Ubukata Y，et al：A novel method of ovarian stimulation for in vitro vertilization：bromocriptine－rebound method.Fertil Steril 1996；66：271－274.
259.FDALabel（2014－08－01）－JARDIANCE（Empagliflozin Tablets）（Boehringer Ingelheim Pharmaceuticals，Inc.）
260.Goto Y，Hotta N，Shigeta Y，et al：Effects of an aldose reductase inhibitor，epalrestat，on diabetic neuropathy.Clinical benefit and indication for the drug assessed from the results of a placebo－controlled double－blind study.Biomed Pharmacother 1995；49：269－277.
261.Kaakeh Y，Kanjee S，Boone K，et al：Liraglutide－induced acute kidney injury.Pharmacotherapy 2012；32（1）：e7－e11.
262.FDALabel（2015－09－25）－Tresiba（Insulin Degludec Injection）（Novo Nordisk Inc.）
263.FDALabel（2013－10－18）－LANTUS［Insulin Glargine（rDNA origin）Injection］（sanofiaventis U.S.LLC）
264.Product Information：NovoLog（R）subcutaneous injection，insulin aspart（rDNA origin）subcutaneous injection.Novo Nordisk Inc，Princeton，NJ，2010.
265.Product Information：THYROGEN（R）IM injection，thyrotropin alfa IM injection.Genzyme Corporation，Cambridge，MA，2007.
266.Product Information：liothyronine sodium IV injection，liothyronine sodium IV injection.X－Gen Pharmaceuticals，Inc，Northport，NY，2006
267.Product Information：TIROSINT（R）oral capsules，levothyroxine sodium oral capsules.Akrimax Pharmaceuticals LLC，Cranford，NJ，2010.
268.Fong PC，Pun KK，Tai YT，et al：Propylthiouracil hypersensitivity with circumstantial evidence for drug－induced reversible sensorineural deafness：a case report.Horm Res 1991；35：132－136
269.Product Information：TAPAZOLE（R）tablets，methimazole tablets.King Pharmaceuticals Inc.，Bristol，TN，2004.
270.Pasquier E，Genereau T，Baudrimont M，et al：Biopsy－proven myositis with microvasculitis in association with carbimazole.Lancet 1991；338：1082－1083.
271.Product Information：calcitriol oral solution，calcitriol oral solution.Roxane Laboratories，Inc，Columbus，OH，2005.
272.Sung RJ，Olukotun AY，Baird CL，et al：Efficacy and safety of oral nadolol for exercise－induced ventricular arrhythmias.Am J Cardiol 1987a；60：15D－20D.
273.Buckmiller LM，Munson PD，Dyamenahalli U，et al：Propranolol for infantile hemangiomas：early experience at a tertiary vascular anomalies center.Laryngoscope 2010；120（4）：676－681.
274.Gretzer I，Alvan G，Duner H，et al：Betablocking effect and pharmacokinetics of pindolol in young and elderly hypertensive patients.Eur J Clin Pharmacol 1986；31：415－418.
275.FDALabel（2011－02－11）－HECTOROL（Doxercalciferol Capsules）（Genzyme Corporation）
276.FDALabel（2011－04－06）－ZEMPLAR（Paricalcitol Injection）（Abbott Laboratories）
277.Product Information：FORTEO（R）subcutaneous injection，teriparatide subcutaneous injection.Eli Lilly and Company，Indianapolis，IN，2009.
278.Wagayama H，Shiraki K，Sugimoto K，et al：Fatal fulminant hepatic failure associated with benzbromarone（letter）.J Hepatol 2000；32（5）：874
279.Product Information：probenecid oral tablets，probenecid oral tablets.Watson Laboratories，Inc，Corona，CA，2003.
280.FDALabel（2011－01－28）－ULORIC（Febuxostat Tablet）（Takeda Pharmaceuticals America，Inc.）
281.Lange U，Schumann C，＆Schmidt KL：Current aspects of colchicine therapy classical indications and new therapeutic uses.Eur J Med Res 2001；6：150－160.
282.Walter－Sack I，de Vries JX，Ernst B，et al：Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients－therapeutic equivalence to allopurinol.J Rheumatol 1996；23：498－501.
283.Martin RL，McSweeney GW，＆Schneider J：Fatal pemphigus vulgaris in a patient taking piroxicam（letter）.N Engl J Med 1983；309：795－796.
284.Turnheim K，Krivanek P，＆Oberbauer R：Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.Br J Clin Pharmacol 1999a；48：501－509.
285.FDALabel（2014－08－01）－LUMIZYME（Alglucosidase Alfa for Injection）（Genzyme Corporation）
286.Product Information：Fabrazyme（R）IV injection，agalsidase beta IV injection.Genzyme Corporation，Cambridge，MA，2008.
287.Product Information：ELAPRASE（TM）IV solution，idursulfase IV solution.Shire Human Genetic Therapies，Inc，Cambridge，MA，2007.
288.Product Information：REGRANEX（R）topical gel，becaplermin topical gel.Ortho－McNeil，Raritan，NJ，2011.
289.Product Information：BUPHENYL（R）oral tablets，powder，sodium phenylbutyrate oral tablets，powder.Ucyclyd Pharma，Inc，Scottsdale，AZ，2009
290.FDALabel（2014－12－19）－Ganirelix Acetate Injection（ORGANON USA INC）
291.Product Information：KUVAN（TM）oral tablets，sapropterin dihydrochloride oral tablets.Bio-Marin Pharmaceutical，Inc，Novato，CA，2007.
292.Product Information：GlucaGen（R）intravenous intramuscular subcutaneous injection，glucagon rDNA origin intravenous intramuscular subcutaneous injection.Novo Nordisk Inc.，Princeton，NJ，2010.
293.Bohm S，Oriana S，Spatti G，et al：Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma.Oncology 1999；57：115－120.
294.FDALabel（2013－03－26）－NAGLAZYME（Galsulfase Injection）（BioMarin Pharmaceutical Inc.）
295.FDALabel（2014－12－19）－Ganirelix Acetate Injection（ORGANON USA INC）
296.Giusti M，Porcella E，Carraro A，et al：A cross－over study with the two novel dopaminergic drugs cabergoline and quinagolide in hyperprolactinemic patients.J Endocrinol Invest 1994；17：51－57.
297.FDALabel（2013－12－19）－KUVAN（Sapropterin Dihydrochloride Tablets，Powder for Oral Solution）（Zogenix，Inc.）
298.FDALabel（2010－02－26）－VPRIV（Velaglucerase Alfa for injection）（Shire Human Genetic Therapies，Inc.）
299.FDALabel（2014－02－14）－VIMIZIM（Elosulfase Alfa Injection）（BioMarin Pharmaceutical Inc.）
300.Product Information：GLUCAGEN（R）HYPOKIT injection，glucagon［rDNA origin］injection.Novo Nordisk，Inc，Princeton，NJ，2004.
301.Product Information：GlucaGen（R）intravenous intramuscular subcutaneous injection，glucagon rDNA origin intravenous intramuscular subcutaneous injection.Novo Nordisk Inc.，Princeton，NJ，2010.
302.Product Information：VAPRISOL intravenous injection，conivaptan HCl intravenous injection.Astellas Pharma US，Inc.（per manufacturer），Deerfield，IL，2012.
303.Schrier RW，Gross P，Gheorghiade M，et al：Tolvaptan，a Selective Oral Vasopressin V2－Receptor Antagonist，for Hyponatremia.N Engl J Med 2006；355（20）：2099－2112.
304.Sheahan，Timothy P.；Sims，Amy C.；Graham，Rachel L.；Menachery，Vineet D.；Gralinski，Lisa E.；Case，James B.；Leist，Sarah R.；Pyrc，Krzysztof；Feng，Joy Y.；Trantcheva，Iva；Bannister，Roy；Park，Yeojin；Babusis，Darius；Clarke，Michael O.；Mackman，Richard L.；Spahn，Jamie E.；Palmiotti，Christopher A.；Siegel，Dustin；Ray，Adrian S.；Cihlar，Tomas；Jordan，Robert；Denison，Mark R.；Baric，Ralph S.Broad－spectrum antiviral GS－5734 inhibits both epidemic and zoonotic coronaviruses.Science Translational Medicine.2017，396（9）［2020－01－29］.ISSN 1946－6234.doi：10.1126／scitranslmed.aal3653.
305.Timothy P.Sheahan；Amy C.Sims；Sarah R.Leist.Comparative therapeutic efficacy of remdesivir and combination lopinavir，ritonavir，and interferon beta against MERS－CoV.Nature Communications.2020，222（11）［2020－01－29］.
306.Furuta Y，Takahashi K，Shiraki K，et al.T－705（favipiravir）and related compounds：Novel broad－spectrum inhibitors of RNA viral infections［J］.Antiviral Res，2009，82（3）：95－102.